Leadership Team 2012-2013
Philip Zhang, Ph. D., J. D.
Co-Founder and Co-Managing Principal, Milstein Zhang & Wu LLC, Newton, MA
Zhiyong Yang, Ph. D.
Senior Principal Scientist, Pfizer Inc., Cambridge, MA
Qinglin Che, Ph. D.
Research Scientist, Syntha Pharmaceuticals, Inc., Lexington, MA
Sue Ma, M. D.
Scientist II, Novartis Institute of BioMedical Research, Cambridge, MA
Executive Committee Members
Qingqing Cao, Ph. D.
Sr. R&D Engineer, Becton Dickinson, Bedford, MA
Steven Du, MD, PhD, MBA
Senior Director, AMAG Pharmaceuticals, Inc., Lexington, MA
Sr. Scientist, Arsenal Medical Inc. Watertown, MA
Kevin Fang, Ph. D.
Sr. Director of Medicinal Chemistry, Sunovion Pharmaceuticals Inc., Marlborough, MA
Henry Gu, J. D.
Counsel, WilmerHale, Boston, MA
Fred Hu, Ph. D.
Executive Director of Discovery Chemistry Services, ChemPartner, Shanghai, China
Jia Huang, Ph. D.
Scientist, Allergan Inc., Medford, MA
Shengfang Jin, Ph. D.
Director/Cell Biology, Agios Pharmaceuticals, Inc., Cambridge, MA
Jinbo Lee, Ph. D.
President, Sage Partner International Inc., Cambridge, MA
Business Development Associate, AstraZeneca, Waltham, MA
Howard (Hao) Li, Ph. D.
Associate Director, Program Office, Novartis Institutes of Biomedical Research, Inc., Cambridge, MA
Vice President, Wuxi Howfond Biopharma, Co. Ltd., Jiangshu, China
Susan Qu, Ph.D. MBA
Principal Project Manager, Genzyme Corporation, a division of Sanofi, Framingham, MA
Senior Market Research Analyst, Boston Biomedical Consultants, Waltham, MA
General Manager, Callisyn Biomedical, Inc, North Andover, MA
Ze Tian, Ph. D.
Instructor, Dana Farber Cancer Institute/Harvard Medical School, Boston, MA
Yikai Wang, Ph. D.
The Broad Institute, Cambridge, MA
Yongzhong Wang, Ph. D.
Deputy General Manager, Kanghong Biotechnology Co. Ltd., Chengdu, China
Yueming Wang, MBA
Deputy General Manager, Tide Pharmaceutical Co. Ltd., Beijing, China
Zhigang Wang, Ph. D.
Principal Scientist, Celgene Avilomics Research, Bedford, MA
Roger Xie, Ph. D.
Chief Executive Officer, Conform Pharmaceuticals, Inc., Cambridge, MA
Li Xing, Ph. D.
Senior Principal Scientist, Pfizer, Inc. Cambridge, MA
Xiang Y. Yu, Ph. D.
Principal Investigator, Ironwood Pharmaceuticals, Inc. Cambridge, MA
Director, Sciligence, Weston, MA
Wei Zhang, Ph. D.
Staff Scientist, Siemens Healthcare Diagnostics, Norwood , MA
Weiyi(Wendy) Zhang, Ph. D.
President, Boston Lincoln International, Lincoln, MA
Youxin Zhang, Ph. D.
Senior Consultant, Navigant Consulting, Boston, MA
Zhendong Zhu, Ph. D.
Principal Investigator, Celgene Avilomics Research, Bedford, MA
Board of Directors
Zhihong Chen, Ph. D.; Immediate Past President
Principal Scientist, Eisai Inc., Andover, MA
Chaoyang Dai, Ph. D.
Vice President of Operations, Acebright, Inc. Bedford, MA
Jun Han, Ph. D.; Founding President
CEO, SOTA International LLC, Boston, MA
Shiwen Lin, Ph. D.; Chairman of the Board
Associate Director, Process & Analytical Technologies, Agenus, Inc. Lexington, MA
Lixin Shen, Ph. D.
President and CEO, Wuxi Howfond Biopharma Co., Ltd., Jiangsu, China
Zhao-Kui Wan, Ph. D.; Immediate Past-President
Sr. Principal Scientist, Pfizer Inc., Cambridge, MA
Yihan Wang, Ph. D.;
Associate Director/Chemistry, ARIAD Pharmaceuticals, Inc., Cambridge, MA
Erxi Wu, Ph. D.
Assistant Prof., North Dakota State University, Fargo, ND
Junjun Wu, Ph. D.; Past President (2007-2009)
CEO,WuXi AllNature Biotech LLC, Jiangsu, China
CABA Legal Council
Attorney at Law, Lynch, DeSimone & Nylen, LLP, Boston, MA
Youssef Bennani, Ph. D.
Vice President/Discovery Chemistry, Vertex Pharmaceuticals Inc., Cambridge, MA
Tim Clackson, Ph. D.
President of Research and Development and Chief Scientific Officer, Ariad Pharmaceuticals Inc., Cambridge, MA
Yuan-Hua Ding, Ph. D.
Senior Director & Head of External R&D Innovation - Asia, Pfizer
Pierre Dodion, M. D., MBA
Sr. VP, Corporate Development, Ariad Pharmaceuticals Inc., Cambridge, MA
Chen Li, Ph. D.
Chief Executive Officer, Hua Medicine, Inc., Shanghai, China
Luke Li, Ph. D.
Exec Director, Head of Global Biotherapeutic Technologies, Bio-Innovation, Pfizer
Shi Li, Ph. D.
CEO, Zerun Biotechnology, Shanghai, CHINA
Yuanli Liu, Ph. D.
Director of China Initiative, Sr. Lecturer on International Health, Dept. of Global Health and Population, Harvard School of Public Health
Dawei Ma , Ph. D.
Professor, Shanghai Institute of Organic Chemistry, Shanghai, China
Tarek Mansour, Ph. D.
EVP of Research & Development, Xenon Pharmaceuticals Inc., Vancouver, Canada
Chairman, Sino Biopharmaceutical Ltd., Beijing, China
John Piwinski, Ph. D.
Principal, JJPiwinski Pharma Consulting, LLC, New York, NY
Steve Projan, Ph. D.
Sr. V.P. R&D, Innovative Medicines Head of Infectious Diseases & Vaccines, MedImmune, Gaithersburg, MD
Tomi Sawyer, Ph. D.
Chief Scientific Officer and Senior Vice-President, Aileron Therapeutics, Cambridge, MA
Liming Shao, Ph. D.
Senior Director/Medicinal Chemistry, Sepracor Inc., Marlborough, MA
Suvit Thaisrivongs, Ph. D.
Vice President, Pfizer, Inc., Cambridge. MA
Roger Tung, Ph. D.
CEO and President, Concert Pharmaceuticals, Lexington, MA
Yibin Xiang, Ph. D.
Senior Director/Medicinal Chemistry, Genzyme Corporation, Cambridge, MA
Gangfeng Xu, Ph. D.
Divisional Vice President, Corporate Licensing & Acquisitions at Abbott Laboratories
Steve Yang, Ph. D.
Head of R&D, Asia & Emerging Markets, AstraZeneca
Howard Yuwen, Ph. D.
Executive Directorand Head of North America Regulatory Affairs, Alexion Pharmaceuticals, Inc., Cheshire, CT